Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Amzak Capital Management, Llc and Zosano Pharma Corp (NASDAQ:ZSAN)

Page 1 of 8

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Amzak Capital Management 118,033 5,269,846 118,033 5,269,846 5,269,846 13.51%
Michael D. Kazma 5,269,846 5,269,846 5,269,846 13.51%
Gerry Kazma 5,269,846 5,269,846 5,269,846 13.51%

Page 1 of 8 – SEC Filing

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 


 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

ZOSANO PHARMA CORPORATION

(Name of Issuer)

Common Stock, $0.0001 par value

(Title of Class of Securities)

98979H103

(CUSIP Number)

March 22, 2017

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed.

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


Follow Zosano Pharma Corp (NASDAQ:ZSAN)
Trade (NASDAQ:ZSAN) Now!
Page 1 of 8